BPC-157 is classified as an experimental peptide, as it is still being examined for its safety and broader effects on the human body
The human equivalent of roughly 0.035 mg represents a tiny fraction of the standard skin rejuvenation dose, suggesting that neurological benefits may occur alongside skin improvements at typical protocol dosages
Cartilage and Tissue Repair: Has been studied to promote the healing of tendons, ligaments, cartilage, muscles, wounds, and surgical incisions
Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells
However, older adults are also more likely to be taking multiple medications, and peptide interactions with common medications for hypertension, diabetes, and cardiovascular disease have not been systematically studied